| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/28/1999 | EP0931541A1 Composition containing a procysteine and polyol combination |
| 07/28/1999 | EP0931092A2 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 07/28/1999 | EP0931087A1 Novel pyranoside derivatives |
| 07/28/1999 | EP0931086A1 Tetrahydronaphthalene derivatives and their therapeutic use |
| 07/28/1999 | EP0931075A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 07/28/1999 | EP0931045A1 Matrix metalloproteinase inhibitors and their therapeutic uses |
| 07/28/1999 | EP0930888A1 Pharmaceutical and cosmetic antiacne formulations containing plant extracts (krameria triandra or mesua ferrea) |
| 07/28/1999 | EP0930886A1 Formulation for use in the prevention of pathogen induced diseases including hiv and hsv |
| 07/28/1999 | EP0930876A2 Use of sex steroid function modulators to treat wounds and fibrotic disorders |
| 07/28/1999 | EP0930869A1 Deodorizing preparations |
| 07/28/1999 | EP0766665B1 Metalloproteinase inhibitors |
| 07/28/1999 | CN1223870A 银屑病胶囊 Psoriasis Capsules |
| 07/28/1999 | CN1223862A External use medicine for treating open wound |
| 07/28/1999 | CN1223860A Use of calomelas in pharmacy |
| 07/28/1999 | CN1223856A 天然植物面膜 Natural plant mask |
| 07/27/1999 | US5929123 Antioxidant compounds |
| 07/27/1999 | US5929056 Accesible from readily available starting materials to be used for wound healing and in cosmetics |
| 07/27/1999 | US5929048 Treatment of conditions and disease |
| 07/27/1999 | US5929040 Method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 07/27/1999 | US5928654 Modulating body/cranial hair growth with lipoxygenase/cyclooxygenase inhibitors |
| 07/27/1999 | CA2181175C Dihydro pyrazolopyrroles |
| 07/22/1999 | WO1999036519A1 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME |
| 07/22/1999 | WO1999036478A1 Color shifting film glitter |
| 07/22/1999 | WO1999036424A1 Piperazino derivatives as neurokinin antagonists |
| 07/22/1999 | WO1999036077A1 Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
| 07/22/1999 | WO1999036069A1 Il-8 receptor antagonists |
| 07/22/1999 | WO1999027793A3 An antimicrobial composition |
| 07/22/1999 | WO1999024042A3 Stable antiandrogenic gel composition |
| 07/22/1999 | CA2318195A1 Il-8 receptor antagonists |
| 07/22/1999 | CA2317813A1 Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
| 07/22/1999 | CA2317760A1 Piperazino derivatives as neurokinin antagonists |
| 07/21/1999 | EP0930310A1 Isocoumarin derivatives and use thereof in drugs |
| 07/21/1999 | EP0930069A2 Compositions for the reduction of scarring |
| 07/21/1999 | EP0930066A2 Low tack lotion, gels and creams |
| 07/21/1999 | EP0930065A2 Alcohol based anti-microbial compositions with cosmetic appearance |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929568A2 Pharmaceutical compositions for the treatment of immune disorders |
| 07/21/1999 | EP0929554A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 07/21/1999 | EP0929542A1 Compounds for and a method of inhibiting matrix metalloproteinases |
| 07/21/1999 | EP0929530A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 07/21/1999 | EP0929516A1 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect |
| 07/21/1999 | EP0929322A1 Methods and compositions for programming an organic matrix for remodeling into a target tissue |
| 07/21/1999 | EP0929302A1 Il-8 receptor antagonists |
| 07/21/1999 | EP0929291A1 Liquid personal cleansing compositions which contain an encapsulated lipophilic skin moisturizing agent comprised of relatively large droplets |
| 07/21/1999 | EP0929288A1 Skin care composition containing an amide and retinol or retinyl ester |
| 07/21/1999 | CN1223690A Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 07/21/1999 | CN1223654A N-[4-(heteroarylmethyl) phenyl]-heteroarylamines |
| 07/21/1999 | CN1223651A Substituted indazole derivatives and their use as phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) inhibitors |
| 07/21/1999 | CN1223132A Medicine for curing dermatosis |
| 07/21/1999 | CN1044245C Tricyclic dicarbonyl derivatives, medicinal compositions and use thereof |
| 07/20/1999 | US5925679 Glycol base with azelaic acid and acid ph for skin disorders like acne, hair loss and wrinkling |
| 07/20/1999 | US5925654 Antiinflammatory agents and enzyme inhibitors |
| 07/20/1999 | US5925649 Ascomycins |
| 07/20/1999 | US5925626 Hyaluronic acid fractions having pharmaceutical activity, and pharmaceutical compositions containing the same |
| 07/20/1999 | US5925547 Nucleic acid encoding novel protein domain which binds tyrosine phosphorylated proteins |
| 07/20/1999 | US5925539 Human pelota homolog |
| 07/20/1999 | US5925369 Bis alkanoyl esters of carnitine having bactericidal, fungicidal and antiprotozoal activity |
| 07/20/1999 | US5925364 Cosmetic or dermatological composition comprising an oil-in-water emulsion comprising oily globules with a lamellar liquid crystal coating |
| 07/20/1999 | US5925363 Cosmetic composition containing, in combination, a superoxide-dismutase and a melanin pigment |
| 07/20/1999 | US5925357 Extracts of plants |
| 07/20/1999 | US5925351 Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 07/20/1999 | US5925350 Use of preparation comprising a plasminogen activator to improve wound healing |
| 07/20/1999 | US5925348 Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin |
| 07/20/1999 | US5925341 Nanoemulsion based on nonionic amphiphilic lipids and aminated silicones and uses |
| 07/20/1999 | CA1340667C Peptides having bradykinin antagonist action |
| 07/15/1999 | WO1999035253A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035252A2 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035243A2 Extension of cellular lifespan, methods and reagents |
| 07/15/1999 | WO1999035168A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035166A1 Compounds and methods for modulating occludin related tissue permeability |
| 07/15/1999 | WO1999035163A1 Phenylalanine derivatives |
| 07/15/1999 | WO1999035146A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 07/15/1999 | WO1999035124A1 Matrix metalloprotease inhibitors |
| 07/15/1999 | WO1999035116A1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments |
| 07/15/1999 | WO1999034827A1 Activated t-cells and their uses |
| 07/15/1999 | WO1999034784A2 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 07/15/1999 | WO1999034783A1 USE OF PPAR-η ACTIVATORS IN DERMATOLOGY |
| 07/15/1999 | WO1999034771A1 Composition to stop hairloss |
| 07/15/1999 | WO1999034763A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis |
| 07/15/1999 | WO1999034676A1 Method of synthesis of derivatives of aloesin |
| 07/15/1999 | CA2351624A1 Compounds and methods for modulating tissue permeability |
| 07/15/1999 | CA2317382A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316973A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316864A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2315265A1 Extension of cellular lifespan, methods and reagents |
| 07/14/1999 | EP0928789A1 6-phenyltetrahydro-1,3-oxazin-2-one derivatives and medicinal compositions containing the same |
| 07/14/1999 | EP0928788A1 Imidazolidin-4-one derivatives useful as anticancer agents |
| 07/14/1999 | EP0928337A1 A human protein tyrosine kinase |
| 07/14/1999 | EP0928203A1 Gene therapy for inhibition of angiogenesis |
| 07/14/1999 | EP0928200A2 Therapeutic combinations of rar antagonists and rxr agonists |
| 07/14/1999 | EP0928193A1 Use of 1-hydroxy-2-pyridones for the treatment of skin diseases |
| 07/14/1999 | EP0928187A1 Antibacterial composition |
| 07/14/1999 | CN1222387A Lotion for treating anal fistula and gynopathy |
| 07/14/1999 | CN1222368A Preparation of ointment for curing burns and scalds and promoting tissue generation |
| 07/14/1999 | CN1222361A Zhongluo capsule as hair tonic |
| 07/14/1999 | CN1222344A Chinese medicinal shampoo of natural plant ingredients |
| 07/13/1999 | US5922853 Human pelota homolog |
| 07/13/1999 | US5922846 Process for refolding recombinantly produced TGF-β-like proteins |
| 07/13/1999 | US5922761 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 07/13/1999 | US5922747 Comprising testosterone reductase used for treatment of acne, alopacia, skin and glandular disorders, prostatic hypertropy, |